glp-1 coverage news today insurers Medicare obesity drug starting July 1 Global Health Brief: The rise

The CEO of Novo Nordisk (NVO), the maker of Ozempic and Wegovy, said last year that food company executives were so scared they were calling him for advice on how to adapt to the new world of weight loss drugs

Monitor yourself for increased appetite suppression or mild nausea over the next few days

Progress may not always be linear, and celebrating non-scale victorieslike increased energy, better mobility, or a healthier relationship with foodis just as important as the number on the scale

On April 3, 2026, Gallagher posted a longer defense of the white-label telemedicine model: Watching in realtime as people learn about white label, drop shipping, and affiliate marketing is like seeing cavemen fire bad White label telemedicine is a huge benefit with a net positive for humanity

It is important to note that these mechanisms remain theoretical and are based largely on preclinical research

Whether you feel GLPs are working brilliantly for you or not, you can see why it is still important to use them as a springboard for your weight optimization journey and not a magic bullet